'This Is a Life and Death Matter': DEA Faces Tsunami of Criticism on Proposed Telehealth-Controlled Substances Rules - Behavioral Health Business
DEA faces intense criticism over proposed telehealth-controlled substances rules, potentially delaying or altering regulations that affect cross-state prescribing.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; final rule expected later in 2024.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Proposed DEA rules for telehealth-controlled substances prescribing are under heavy criticism, increasing likelihood of changes or delays in finalization.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Monitor DEA announcements and prepare for potential rule changes; consider contingency plans for prescribing controlled substances via telehealth.
Deadline
Ongoing; final rule expected later in 2024.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis